From: Influx of multidrug-resistant organisms by country-to-country transfer of patients
Species | No. (%) of isolates | No. (%) of MDR–GN | No. (%) XDR–GN | No. and type of Carbapenemase in XDR–GN |
---|---|---|---|---|
Escherichia coli | 42 (40.4) | 39 (65) | 3 (21.4) | 1 none |
1 NDM–1 | ||||
1 KPC | ||||
MRSA | 18 (17.3) | N/A | N/A | N/A |
Klebsiella pneumoniae | 18 (17.3) | 14 (23.3) | 4 (28.6) | 2 none |
1 NDM–1 | ||||
1 OXA–48 | ||||
VRE (all E. faecium) | 12 (11.5) | N/A | N/A | N/A |
Pseudomonas aeruginosa | 6 (5.8) | 3 (5) | 3 (21.4) | 2 none |
1 VIM–1 | ||||
Acinetobacter baumanii | 3 (2.9) | 0 (0) | 3 (21.4) | 3 OXA–23 |
Enterobacter cloacae | 3 (2.9) | 2 (3.3) | 1 (7.1) | 1 VIM–4 |
Proteus mirabilis | 1 (1.0) | 1 (1.7) | 0 (0) | N/A |
Klebsiella oxytoca | 1 (1.0) | 1 (1.7) | 0 (0) | N/A |
total | 104 (100) | 60 (100) | 14 (100) | 9 |